• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用单克隆抗体和多克隆抗体对人氨肽酶进行的免疫化学研究:氨肽酶缺乏症患者红细胞中不存在氨肽酶亚基。

Immunochemical studies of human prolidase with monoclonal and polyclonal antibodies: absence of the subunit of prolidase in erythrocytes from a patient with prolidase deficiency.

作者信息

Endo F, Motohara K, Indo Y, Matsuda I

机构信息

Department of Pediatrics, Kumamoto University Medical School, Japan.

出版信息

Pediatr Res. 1987 Dec;22(6):627-33. doi: 10.1203/00006450-198712000-00002.

DOI:10.1203/00006450-198712000-00002
PMID:3324031
Abstract

Prolidase was highly purified from human liver and erythrocytes. NaDodSO4/acrylamide gel electrophoresis revealed that these preparations contained a major protein with MW = 56,000. The mass of prolidase was estimated on gel filtration to be MW = 97,000, for both enzyme preparations. A monoclonal antibody was raised against the liver enzyme and a specific antiserum against the erythrocyte enzyme. The monoclonal antibody (EP-2) recognized prolidase from erythrocytes and liver, in equal proportions. The antiserum also recognized the enzyme from erythrocytes and liver. Immunoprecipitation studies with these antibodies suggested only a single species of prolidase in erythrocytes and liver. Using an immobilized monoclonal antibody (EP-2) as an immunoadsorbent, prolidase was partially purified from crude extracts, and the protein of the partially purified enzyme was identified by immunoblotting using antiserum. A protein band with a MW = 56,000 was demonstrated specifically when crude extracts from the liver and erythrocytes were examined using NaDodSO4/acrylamide gel electrophoresis. The subunit protein was absent in erythrocytes from a patient with prolidase deficiency. We propose that the absence of the subunit is one cause of the prolidase deficiency.

摘要

从人肝脏和红细胞中高度纯化了脯氨酰肽酶。十二烷基硫酸钠/丙烯酰胺凝胶电泳显示,这些制剂含有一种主要蛋白质,其分子量为56,000。两种酶制剂在凝胶过滤法中测得的脯氨酰肽酶分子量均为97,000。制备了针对肝脏酶的单克隆抗体和针对红细胞酶的特异性抗血清。单克隆抗体(EP - 2)对来自红细胞和肝脏的脯氨酰肽酶的识别比例相同。抗血清也能识别来自红细胞和肝脏的该酶。用这些抗体进行的免疫沉淀研究表明,红细胞和肝脏中仅有一种脯氨酰肽酶。使用固定化单克隆抗体(EP - 2)作为免疫吸附剂,从粗提物中部分纯化了脯氨酰肽酶,并使用抗血清通过免疫印迹法鉴定了部分纯化酶的蛋白质。当使用十二烷基硫酸钠/丙烯酰胺凝胶电泳检测肝脏和红细胞的粗提物时,特异性显示出一条分子量为56,000的蛋白带。脯氨酰肽酶缺乏症患者的红细胞中不存在该亚基蛋白。我们认为该亚基的缺失是脯氨酰肽酶缺乏症的一个原因。

相似文献

1
Immunochemical studies of human prolidase with monoclonal and polyclonal antibodies: absence of the subunit of prolidase in erythrocytes from a patient with prolidase deficiency.用单克隆抗体和多克隆抗体对人氨肽酶进行的免疫化学研究:氨肽酶缺乏症患者红细胞中不存在氨肽酶亚基。
Pediatr Res. 1987 Dec;22(6):627-33. doi: 10.1203/00006450-198712000-00002.
2
Human kidney prolidase--purification, preincubation properties and immunological reactivity.
Int J Biochem. 1994 Feb;26(2):207-14. doi: 10.1016/0020-711x(94)90147-3.
3
Characterization of prolidase activity in erythrocytes from a patient with prolidase deficiency: comparison with prolidase I and II purified from normal human erythrocytes.对一名氨肽酶缺乏症患者红细胞中氨肽酶活性的表征:与从正常人红细胞中纯化的氨肽酶I和II的比较。
Clin Biochem. 2005 Jul;38(7):625-31. doi: 10.1016/j.clinbiochem.2005.03.007.
4
In situ activation of human erythrocyte prolidase: potential for enzyme replacement therapy in prolidase deficiency.人红细胞脯氨酰肽酶的原位激活:脯氨酰肽酶缺乏症酶替代疗法的潜力
Pediatr Res. 1988 Dec;24(6):709-12. doi: 10.1203/00006450-198812000-00012.
5
Characterization of prolidase I and II from erythrocytes of a control, a patient with prolidase deficiency and her mother.
Clin Chim Acta. 1990 Jan 31;187(1):1-9. doi: 10.1016/0009-8981(90)90256-r.
6
Purification and characterization of activated human erythrocyte prolidase.
Biochem Cell Biol. 1989 Jan;67(1):34-41. doi: 10.1139/o89-005.
7
Immunoaffinity purification of human erythrocyte prolidase.
Clin Chim Acta. 1988 Aug 31;176(2):143-9. doi: 10.1016/0009-8981(88)90201-x.
8
Immunochemical analysis of prolidase deficiency and molecular cloning of cDNA for prolidase of human liver.脯氨酰二肽酶缺乏症的免疫化学分析及人肝脏脯氨酰二肽酶cDNA的分子克隆。
J Inherit Metab Dis. 1987;10(3):305-7. doi: 10.1007/BF01800088.
9
Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients.脯氨酰肽酶缺乏症:意大利患者红细胞和皮肤成纤维细胞脯氨酰肽酶活性的生化研究
Haematologica. 1994 Jan-Feb;79(1):13-8.
10
Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes.脯氨酰肽酶缺乏症的生化基础。多肽和RNA表型及其与临床表型的关系。
J Clin Invest. 1990 Jan;85(1):162-9. doi: 10.1172/JCI114407.

引用本文的文献

1
PROLIDASE: A Review from Discovery to its Role in Health and Disease.脯氨酰肽酶:从发现到其在健康与疾病中作用的综述
Front Mol Biosci. 2021 Aug 31;8:723003. doi: 10.3389/fmolb.2021.723003. eCollection 2021.
2
Quantitative analysis of the natural history of prolidase deficiency: description of 17 families and systematic review of published cases.脯氨酸肽酶缺乏症自然病史的定量分析:17 个家系的描述及已发表病例的系统回顾
Genet Med. 2021 Sep;23(9):1604-1615. doi: 10.1038/s41436-021-01200-2. Epub 2021 May 26.
3
Prolidase deficiency breaks tolerance to lupus-associated antigens.
脯氨肽酶缺乏症会破坏对狼疮相关抗原的耐受性。
Int J Rheum Dis. 2013 Dec;16(6):674-80. doi: 10.1111/1756-185X.12254. Epub 2013 Dec 14.
4
Cloning and expression of a gene encoding a bacterial enzyme for decontamination of organophosphorus nerve agents and nucleotide sequence of the enzyme.一种用于有机磷神经毒剂解毒的细菌酶编码基因的克隆、表达及该酶的核苷酸序列
Appl Environ Microbiol. 1996 May;62(5):1636-41. doi: 10.1128/aem.62.5.1636-1641.1996.
5
Prolidase deficiency: biochemical classification of alleles.脯氨酰肽酶缺乏症:等位基因的生化分类
Am J Hum Genet. 1989 May;44(5):731-40.
6
Deduced amino acid sequence of human prolidase and molecular analyses of prolidase deficiency.
J Inherit Metab Dis. 1989;12(3):351-4. doi: 10.1007/BF01799240.
7
A single nucleotide change in the prolidase gene in fibroblasts from two patients with polypeptide positive prolidase deficiency. Expression of the mutant enzyme in NIH 3T3 cells.两名多肽阳性脯氨酰二肽酶缺乏症患者成纤维细胞中脯氨酰二肽酶基因的单核苷酸变化。突变酶在NIH 3T3细胞中的表达。
J Clin Invest. 1990 Jul;86(1):351-5. doi: 10.1172/JCI114708.
8
Molecular defect in siblings with prolidase deficiency and absence or presence of clinical symptoms. A 0.8-kb deletion with breakpoints at the short, direct repeat in the PEPD gene and synthesis of abnormal messenger RNA and inactive polypeptide.患有脯氨酰二肽酶缺乏症且有或无临床症状的同胞的分子缺陷。PEPD基因中短的直接重复序列处有一个0.8kb的缺失,导致异常信使核糖核酸的合成及无活性多肽的产生。
J Clin Invest. 1991 Apr;87(4):1171-6. doi: 10.1172/JCI115115.
9
Abnormal mRNA and inactive polypeptide in a patient with prolidase deficiency.一名患有氨肽酶缺乏症患者的异常信使核糖核酸和无活性多肽。
J Inherit Metab Dis. 1991;14(5):777-82. doi: 10.1007/BF01799949.
10
Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes.脯氨酰肽酶缺乏症的生化基础。多肽和RNA表型及其与临床表型的关系。
J Clin Invest. 1990 Jan;85(1):162-9. doi: 10.1172/JCI114407.